approximately 35% of cervical cancer patients are diagnosed with regional disease and 11% with distant-stage disease.Prognosis is strongly related to stage: the 5-year relative survival rate is 91.2% for patients with localized disease, but only 57.8% for patients with regional disease and 17.0% for those with distant disease